Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
2025-12-08 14:36
GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper
2025-12-02 13:00
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine'
2025-11-03 13:26
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine
2025-10-13 12:38
GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea
2025-09-23 09:41
GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal
2025-08-21 13:00
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies
2025-08-18 12:40
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam
2025-07-17 13:56
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal
2025-05-30 15:02
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California
2025-05-14 13:21
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine
2025-04-09 12:00
GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025
2025-02-11 16:40
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment
2024-11-26 08:44
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies
2024-10-29 09:13
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA
2024-09-03 15:59
GC Cell Signs an MOU with PT Bifarma Adiluhung, an affiliate of KALBE group
2024-06-20 08:44
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A
2024-06-10 16:18
GCBP Sponsors 2024 Spring Symposium for KASBP and Present Research Findings
2024-06-04 13:00
GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor
2024-05-28 23:00
GC Biopharma/Novel Pharma's Sanfilippo Syndrome Treatment Obtains FDA IND Clearance
2024-05-21 15:12
1
2
3